We are live on ! Find out more
RL

Ruffer LLP Portfolio holdings

AUM $2.83B
1-Year Est. Return 30.34%
This Fund
S&P 500
This Quarter Est. Return
-8.55%
1 Year Est. Return
+30.34%
3 Year Est. Return
+98.01%
5 Year Est. Return
+139.76%
10 Year Est. Return
+587.97%
AUM
$3.16B
AUM Growth
-$410M
Cap. Flow
-$33.1M
Cap. Flow %
-1.05%
Top 10 Hldgs %
64.23%
Holding
98
New
9
Increased
25
Reduced
29
Closed
8

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$115M
2
CI icon
Cigna
CI
+$76.9M
3
WPM icon
Wheaton Precious Metals
WPM
+$42.8M
4
CAR icon
Avis
CAR
+$40.3M
5
KGC icon
Kinross Gold
KGC
+$36.4M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$183M
2
CNC icon
Centene
CNC
+$137M
3
AXP icon
American Express
AXP
+$42.7M
4
NTR icon
Nutrien
NTR
+$38.8M
5
BMY icon
Bristol-Myers Squibb
BMY
+$19.8M

Sector Composition

Rank Sector Weight
1 Healthcare 31.32%
2 Materials 22.81%
3 Financials 15.4%
4 Consumer Staples 10.93%
5 Energy 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLDG
51
GoldMining Inc
GLDG
$178M
$2.92M 0.09%
2,501,996
– –
NOV icon
52
NOV
NOV
$6.93B
$1.42M 0.05%
106,196
-12,824
-11% -$173K
ORA icon
53
Ormat Technologies
ORA
$6B
$1.36M 0.04%
20,300
– –
DB icon
54
Deutsche Bank
DB
$69B
$1.33M 0.04%
106,500
– –
PM icon
55
Philip Morris
PM
$297B
$1.24M 0.04%
13,000
-66,992
-84% -$6.74M
WFC icon
56
Wells Fargo
WFC
$261B
$1.22M 0.04%
26,000
– –
USB icon
57
US Bancorp
USB
$98.2B
$1.21M 0.04%
20,000
– –
LBPS
58
DELISTED
4D Pharma PLC
LBPS
$1.2M 0.04%
195,954
– –
MKL icon
59
Markel Group
MKL
$23.3B
$1.2M 0.04%
1,000
– –
MTB icon
60
M&T Bank
MTB
$35.7B
$1.16M 0.04%
7,592
+92
+1% +$12.8K
USAS
61
Americas Gold and Silver
USAS
$1.29B
$1.09M 0.03%
579,797
– –
CAG icon
62
Conagra Brands
CAG
$6.94B
$1.07M 0.03%
32,000
– –
CLH icon
63
Clean Harbors
CLH
$16.5B
$1.07M 0.03%
10,000
– –
MLM icon
64
Martin Marietta Materials
MLM
$31.5B
$1.06M 0.03%
3,000
– –
NXST icon
65
Nexstar Media Group
NXST
$5.82B
$1.02M 0.03%
6,683
-48,064
-88% -$7.09M
HRB icon
66
H&R Block
HRB
$5.58B
$1.01M 0.03%
40,000
– –
EAF icon
67
GrafTech
EAF
$175M
$1M 0.03%
9,700
– –
JAZZ icon
68
Jazz Pharmaceuticals
JAZZ
$15.9B
$996K 0.03%
7,702
– –
CMI icon
69
Cummins
CMI
$87.5B
$976K 0.03%
4,300
+1,600
+59% +$375K
DOW icon
70
Dow Inc
DOW
$21.9B
$954K 0.03%
16,363
-33
-0.2% -$2.02K
VSAT icon
71
Viasat
VSAT
$10.6B
$928K 0.03%
16,500
– –
SB icon
72
Safe Bulkers
SB
$795M
$860K 0.03%
163,788
-70,000
-30% -$270K
BTG icon
73
B2Gold
BTG
$5B
$845K 0.03%
+250,000
New +$966K
NOMD icon
74
Nomad Foods
NOMD
$1.66B
$845K 0.03%
30,000
-238,659
-89% -$6.48M
MSFT icon
75
Microsoft
MSFT
$3.45T
$782K 0.02%
2,718
-21
-0.8% -$6.11K
1 2
3
4

Similar funds

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Ruffer LLP's Q3 2021 Portfolio in Review

As of Q3 2021, Ruffer LLP held 98 positions worth $3.16B, down 11% from $3.57B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Ruffer LLP's Q3 2021 filing shows 9 new, 25 increased, 29 reduced and 8 closed positions. Its largest new stake was AstraZeneca: 985,898 shares worth $117M. The largest sale was Alexion Pharmaceuticals, an estimated $183M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Materials and Financials.

  • Ruffer LLP's largest Q3 2021 buy was AstraZeneca: 985,898 shares worth $117M.
  • Ruffer LLP added most to Cigna in Q3 2021, an estimated $76.9M increase.
  • Ruffer LLP's biggest Q3 2021 reduction was Centene, cutting an estimated $137M.
  • Ruffer LLP fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $183M.
  • Ruffer LLP's ten largest holdings make up 64% of its $3.16B portfolio in Q3 2021.
  • Ruffer LLP opened 9 new positions and closed 8 in Q3 2021.
  • Ruffer LLP's portfolio value fell 11% quarter-over-quarter to $3.16B.

Based on Ruffer LLP's 13F filing for Q3 2021, filed 10 Nov 2021.